Penetration enhancers

Advanced Drug Delivery Reviews

Volumn 64, Issue SUPPL., 2012, Pages 128-137

  Williams, Adrian C ^a   Barry, Brian W ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Accelerants; Azone; Dimethylsulphoxide; Lipids; Penetration enhancers; Skin; Terpenes

Indexed keywords

2-PYRROLIDONE; ACCELERANTS; ALKANOLS; AZONE; BARRIER RESISTANCE; CORNEOCYTES; DECANOL; DOSAGE FORMS; INTERCELLULAR LIPIDS; METABOLIC ACTIVITY; PACKING MOTIFS; PENETRATION ENHANCERS; POTENTIAL MECHANISM; POTENTIAL SITES; PROPYLENE GLYCOLS; PYRROLIDONES; SKIN PENETRATION; TERPENES; THERMODYNAMIC ACTIVITY; TRANSDERMAL DRUG DELIVERY;

DIMETHYL SULFOXIDE; ETHANOL; GLYCOLS; OLEFINS; SKIN; SORPTION; TISSUE;

LIPIDS;

1 METHYL 2 PYRROLIDINONE; 2 PYRROLIDINONE; ALCOHOL; ALKANOL; AMMONIUM LACTATE; CAFFEINE; DECYL METHYL SULFOXIDE; DIMETHYL SULFOXIDE; FLUOROURACIL; GLYCOL; HYDROCORTISONE; KERATIN; LAUROCAPRAM; LAURYL ALCOHOL; LIDOCAINE; LIPID; MANNITOL; N,N DIMETHYLACETAMIDE; N,N DIMETHYLFORMAMIDE; NALOXONE; OLEIC ACID; PENETRATION ENHANCING AGENT; PROPYLENE GLYCOL; SOLVENT; SULFAGUANIDINE; SULFOXIDE; SURFACTANT; TERPENE; UNINDEXED DRUG; UREA;

DESMOSOME; DRUG MECHANISM; DRUG SOLUBILITY; DRUG STRUCTURE; HUMAN; HYPERKERATOSIS; ICHTHYOSIS; MEMBRANE TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; REVIEW; SKIN PENETRATION; THERMODYNAMICS; TRANSDERMAL DRUG ADMINISTRATION;

EID: 84870254162     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2012.09.032     Document Type: Review

References (63)

1. Barry B.W. Dermatological Formulations: Percutaneous Absorption 1983, Marcel Dekker, New York.
2. Menon G.K., Lee S.H. Ultrastructural effects of some solvents and vehicles on the stratum corneum and other skin components: evidence for an "extended mosaic-partitioning model of the skin barrier". Dermal Absorption and Toxicity Assessment 1998, Marcel Dekker, New York, Chapter 29. M.S. Roberts, K.A. Walters (Eds.).
3. Bucks D., Maibach H.I. Occlusion does not uniformly enhance penetration in vivo. Percutaneous Absorption; Drugs-Cosmetics-Mechanisms-Methodology 1999, Marcel Dekker, New York, Chapter 4. 3rd ed. R.L. Bronaugh, H.I. Maibach (Eds.).
4. Walkley K. Bound water in stratum corneum measured by differential scanning calorimetry. J. Invest. Dermatol. 1972, 59:225-227.
5. Cornwell P.A., Barry B.W. Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil. J. Pharm. Pharmacol. 1994, 46:261-269.
6. Van Hal D.A., Jeremiasse E., Junginger H.E., Spies F., Bouwstra J.A. Structure of fully hydrated human stratum corneum: a freeze fracture electron microscopy study. J. Invest. Dermatol. 1996, 106:89-95.
7. Elias P.M., Tsai J., Menon G.K., Holleran W.M., Feingold K.R. The potential of metabolic interventions to enhance transdermal drug delivery. JID Symp. Proc. 2002, 7:79-85.
8. Bond J.R., Barry B.W. Limitations of hairless mouse skin as a model for in vitro permeation studies through human skin: hydration damage. J. Invest. Dermatol. 1986, 90:486-489.
9. Kligman A.M. Topical pharmacology and toxicology of dimethylsulfoxide. J. Am. Med. Assoc. 1965, 193:796.
10. Southwell D., Barry B.W. Penetration enhancers for human skin: mode of action of 2-pyrrolidone and dimethylformamide on partition and diffusion of model compounds water, n-alcohols and caffeine. J. Invest. Dermatol. 1983, 80:507-515.
11. Barry B.W., Southwell D., Woodford R. Optimisation of bioavailability of topical steroids: penetration enhancers under occlusion. J. Invest. Dermatol. 1984, 82:49-52.
12. Bennett S.L., Barry B.W., Woodford R. Optimisation of bioavailability of topical steroids: non-occluded penetration enhancers under thermodynamic control. J. Pharm. Pharmacol. 1984, 37:298-304.
13. Oertel R.P. Protein conformational changes induced in human stratum corneum by organic sulphoxides: an infrared spectroscopic investigation. Biopolymer 1997, 16:2329-2345.
14. Anigbogu A.N.C., Williams A.C., Barry B.W., Edwards H.G.M. Fourier transform Raman spectroscopy of interactions between the penetration enhancer dimethylsulphoxide and human stratum corneum. Int. J. Pharm. 1995, 125:265-282.
15. Hoogstraate A.J., Verhoef J., Brussee J., Ijzerman A.P., Spies F., Bodde H.E. Kinetics, ultrastructural aspects and molecular modelling of transdermal peptide flux enhancement by N-alkylazacycloheptanones. Int. J. Pharm. 1991, 76:37-47.
16. Pilgram G.S.K., van der Meulen J., Gooris G.S., Koerten H.K., Bouwstra J.A. The influence of two azones and sebaceous lipids on the lateral organization of lipids isolated from human stratum corneum. Biochim. Biophys. Acta-Biomembr. 2001, 1511:244-254.
17. J.W. Wiechers, Absorption, distribution, metabolism, and exretion of the cutaneous penetration enhancer Azone, Ph.D. thesis, University of Groningen, 1989.
18. Wiechers J.W., de Zeeuw R.A. Transdermal drug delivery: efficacy and potential applications of the penetration enhancer Azone. Drug Des. Deliv. 1990, 6:87-100.
19. Afouna M.I., Fincher T.K., Zaghloul A.A.A., Reddy I.K. Effect of Azone upon the in vivo antiviral efficacy of cidofovir or acyclovir topical formulations in treatment/prevention of cutaneous HSV-1 infections and its correlation with skin target site free drug concentration in hairless mice. Int. J. Pharm. 2003, 253:159-168.
20. Park E.S., Chang S.J., Rhee Y.S., Chi S.C. Effects of adhesives and permeation enhancers on the skin permeation of captopril. Drug Dev. Ind. Pharm. 2001, 27:975-980.
21. Jungbauer F.H.W., Coenraads P.J., Kardaun S.H. Toxic hygroscopic contact reaction to N-methyl-2-pyrrolidone. Contact Dermatitis 2001, 45:303-304.
22. Aungst B.J., Rogers N.J., Shefter E. Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides. Int. J. Pharm. 1986, 33:225-234.
23. Aungst B.J. Structure-effects studies of fatty acid isomers as skin penetration enhancers and skin irritants. Pharm. Res. 1989, 6:244-247.
24. Funke A.P., Schiller R., Motzkus H.W., Günther C., Müller R.H., Lipp R. Transdermal delivery of highly lipophilic drugs: in vitro fluxes of antiestrogens, permeation enhancers, and solvents from liquid formulations. Pharm. Res. 2002, 19:661-668.
25. Santoyo S., Ygartua P. Effect of skin pre-treatment with fatty acids on percutaneous absorption and skin retention of piroxicam after its topical application. Eur. J. Pharm. Biopharm. 2000, 50:245-250.
26. Goodman M., Barry B.W. Lipid-protein-partitioning theory (LPP) theory of skin enhancer activity: finite dose technique. Int. J. Pharm. 1989, 57:29-40.
27. Aboofazeli R., Zia H., Needham T.E. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement. Drug Deliv. 2002, 9:239-247.
28. Takahashi K., Sakano H., Numata N., Kuroda S., Mizuno N. Effect of fatty acid diesters on permeation of anti-inflammatory drugs through rat skin. Drug Dev. Ind. Pharm. 2002, 28:1285-1294.
29. Ongpipattanakul B., Burnette R.R., Potts R.O., Francoeur M.L. Evidence that oleic acid exists in a separate phase within stratum corneum lipids. Pharm. Res. 1991, 7:350-354.
30. Tanojo H., BosvanGeest A., Bouwstra J.A., Junginger H.E., Bodde H.E. In vitro human skin barrier perturbation by oleic acid: thermal analysis and freeze fracture electron microscopy studies. Thermochim. Acta 1997, 293:77-85.
31. Berner B., Mazzenga G.C., Otte J.H., Steffens R.J., Juang R.-H., Ebert C.D. Ethanol: water mutually enhanced transdermal therapeutic system: II. Skin permeation of ethanol and nitroglycerin. J. Pharm. Sci. 1989, 78:402-407.
32. Friend D., Catz P., Heller J., Reid J., Baker R. Transdermal delivery of levonorgestrel I. Alkanols as permeation enhancers. J. Control. Release 1988, 7:243-250.
33. Pershing L.K., Lambert L.D., Knutson K. Mechanism of ethanol-enhanced estradiol permeation across human skin in vivo. Pharm. Res. 1990, 7:170-175.
34. Kurihara-Bergstrom T., Knutson K., De Noble L.J., Goates C.Y. Percutaneous absorption enhancement of an ionic molecule by ethanol-water systems in human skin. Pharm. Res. 1990, 7:762-766.
35. Megrab N.A., Williams A.C., Barry B.W. Oestradiol permeation across human skin, silastic and snake skin membranes: the effects of ethanol/water co-solvent systems. Int. J. Pharm. 1995, 116:101-112.
36. Thomas N.S., Panchagnula R. Transdermal delivery of zidovudine: effect of vehicles on permeation across rat skin and their mechanism of action. Pharm. Sci. 2003, 18:71-79.
37. Morimoto H., Wada Y., Seki T., Sugibayashi K. In vitro skin permeation of morphine hydrochloride during the finite application of penetration-enhancing system containing water, ethanol and l-menthol. Biol. Pharm. Bull. 2002, 25:134-136.
38. Andega S., Kanikkannan N., Singh M. Comparison of the effect of fatty alcohols on the permeation of melatonin between porcine and human skin. J. Control. Release 2001, 77:17-25.
39. Tupker R.A., Pinnagoda J., Nater J.P. The transient and cumulative effect of sodium lauryl sulphate on the epidermal barrier assessed by transepidermal water loss: inter-individual variation. Acta Derm. Venereol. (Stockh.) 1990, 70:1-5.
40. Watkinson A.C., Green D.M., Brain K.R., James V.J., Waters K.A., Azri-Meehan S., Sharma R., Dressler W. Skin penetration of a series of nonoxynol homologues. Perspectives in Percutaneous Penetration 1998, vol. 5b:54-59. STS Publishing, Cardiff.
41. Sarpotdar P.P., Zatz J.L. Percutaneous absorption enhancement by non-ionic surfactants. Drug Dev. Ind. Pharm. 1986, 12:1625-1647.
42. Sarpotdar P.P., Zatz J.L. Evaluation of penetration enhancement of lidocaine by non-ionic surfactants through hairless mouse skin in vitro. J. Pharm. Sci. 1986, 75:176.
43. Yu D., Sanders L.M., Davidson G.W., Marvin M.J., Ling T. Percutaneous absorption of nicardipine and ketorolac in rhesus monkeys. Pharm. Res. 1988, 5:457.
44. Rigg P.C., Barry B.W. Shed snake skin and hairless mouse skin as model membranes for human skin during permeation studies. J. Invest. Dermatol. 1990, 94:235-240.
45. Gloor M., Fluhr J., Wasik B., Gehring W. Clinical effect of salicylic acid and high dose urea applied in standardized NRF formulations. Pharmazie 2001, 56:810-814.
46. Wong O., Tsuzuki N., Nghiem B., Kuehnhoff J., Itoh T., Masaki K., Huntingdon J., Konishi R., Rytting J.H., Higuchi T. Unsaturated cyclic ureas as new non-toxic biodegradable transdermal penetration enhancers: II. Evaluation study. Int. J. Pharm. 1989, 52:191-192.
47. Williams A.C., Barry B.W. Urea analogues in propylene glycol as penetration enhancers in human skin. Int. J. Pharm. 1989, 56:43-50.
48. Williams A.C., Barry B.W. Essential oils as novel human skin penetration enhancers. Int. J. Pharm. 1989, 57:R7-R9.
49. Williams A.C., Barry B.W. Terpenes and the lipid-protein-partititioning theory of skin penetration enhancers. Pharm. Res. 1991, 8:17-24.
50. Williams A.C., Barry B.W. The enhancement index concept applied to terpene penetration enhancers for human skin and model lipophilic (oestradiol) and hydrophilic (5-fluorouracil) drugs. Int. J. Pharm. 1991, 74:157-168.
51. Nagai T., Okabe H., Ogura A., Takayama K. Effect of limonene and related compounds on the percutaneous absorption of indomethacin. Proceedings of the 16th International Symposium on Controlled Release Bioactive Material, Chicago, USA 1989, 181-182.
52. Okabe H., Takayama K., Ogura A., Nagai T. Effect of limonene and related compounds on the percutaneous absorption of indomethacin. Drug Des. Deliv. 1989, 4:313-321.
53. Barry B.W., Williams A.C. Human skin penetration enhancement: the synergy of propylene glycol with terpenes. Proceedings of the 16th International Symposium on Controlled Release Bioactive Material, Chicago, USA 1989, 33-34.
54. Fang J.-Y., Hung C.-F., Chiu H.-C., Wang J.-J., Chan T.-F. Efficacy and irritancy of enhancers on the in vitro and in vivo percutaneous absorption of curcumin. J. Pharm. Pharmacol. 2003, 55:593-601.
55. Cornwell P.A., Barry B.W. Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil. J. Pharm. Pharmacol. 1994, 46:261-269.
56. Kadir R., Barry B.W. α-Bisabolol, a possible safe penetration enhancer for dermal and transdermal therapeutics. Int. J. Pharm. 1991, 70:87-94.
57. Jain A.K., Thomas N.S., Panchagnula R. Transdermal drug delivery of imipramine hydrochloride: I. Effect of terpenes. J. Control. Release 2002, 79:93-101.
58. El-Kattan A.F., Asbill C.S., Michniak B.B. The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems. Int. J. Pharm. 2000, 198:179-189.
59. Monti D., Chetoni P., Burgalassi S., Najarro M., Saettone M.F., Boldrini E. Effect of different terpene-containing essential oils on permeation of estradiol through hairless mouse skin. Int. J. Pharm. 2002, 237:209-214.
60. Cal K., Janicki S., Sznitowska M. In vitro studies on penetration of terpenes from matrix-type transdermal systems through human skin. Int. J. Pharm. 2001, 224:81-88.
61. Cornwell P.A., Barry B.W., Bouwstra J.A., Gooris G.S. Modes of action of terpene penetration enhancers in human skin; differential scanning calorimetry, small-angle X-ray diffraction and enhancer uptake studies. Int. J. Pharm 1996, 127:9-26.
62. Kato A., Ishibashi Y., Miyake Y. Effect of egg-yolk lecithin on transdermal delivery of bunazosin hydrochloride. J. Pharm. Pharmacol. 1987, 39:399-400.
63. Barry B.W. Lipid-protein-partititioning theory of skin penetration enhancement. J. Control. Release 1991, 15:237-248.